Cover Image
市場調查報告書

Charlesson LLC. - 產品平台分析

Charlesson LLC. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 192521
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
Charlesson LLC. - 產品平台分析 Charlesson LLC. - Product Pipeline Review - 2015
出版日期: 2015年05月29日 內容資訊: 英文 25 Pages
簡介

Charlesson LLC. 是開發消耗性眼疾之治療的製藥公司,其產品治療對像為老年性黃斑部病變,糖尿病視網膜病變,眼睛發炎等。此外,也進行前臨床階段的委託研究,追求眼科領域之治療及診斷、評估之可能性。

本報告提供Charlesson LLC.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Charlesson LLC.的基本資料

  • Charlesson LLC.概要
  • 主要資訊
  • 企業資料

Charlesson LLC.:R&D概要

  • 主要的治療範圍

Charlesson LLC.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Charlesson LLC.:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Charlesson LLC.:藥物簡介

  • CLT-005
  • CLT-010
  • CLT-01001
  • CLT-01007
  • CLT-01012
  • E-1086

Charlesson LLC.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Charlesson LLC.:暫停中的計劃

Charlesson LLC.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07105CDB

Summary

Global Markets Direct's, 'Charlesson LLC. - Product Pipeline Review - 2015', provides an overview of the Charlesson LLC.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Charlesson LLC.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Charlesson LLC. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Charlesson LLC.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Charlesson LLC.'s pipeline products

Reasons to buy

  • Evaluate Charlesson LLC.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Charlesson LLC. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Charlesson LLC.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Charlesson LLC. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Charlesson LLC.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Charlesson LLC. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Charlesson LLC. Snapshot
    • Charlesson LLC. Overview
    • Key Information
    • Key Facts
  • Charlesson LLC. - Research and Development Overview
    • Key Therapeutic Areas
  • Charlesson LLC. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Charlesson LLC. - Pipeline Products Glance
    • Charlesson LLC. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Charlesson LLC. - Drug Profiles
    • CLT-005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CLT-010
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CLT-01001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CLT-01007
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CLT-01012
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • E-1086
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Charlesson LLC. - Pipeline Analysis
  • Charlesson LLC. - Pipeline Products by Target
  • Charlesson LLC. - Pipeline Products by Route of Administration
  • Charlesson LLC. - Pipeline Products by Molecule Type
  • Charlesson LLC. - Pipeline Products by Mechanism of Action
  • Charlesson LLC. - Dormant Projects
  • Charlesson LLC. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Charlesson LLC., Key Information
  • Charlesson LLC., Key Facts
  • Charlesson LLC. - Pipeline by Indication, 2015
  • Charlesson LLC. - Pipeline by Stage of Development, 2015
  • Charlesson LLC. - Monotherapy Products in Pipeline, 2015
  • Charlesson LLC. - Preclinical, 2015
  • Charlesson LLC. - Discovery, 2015
  • Charlesson LLC. - Pipeline by Target, 2015
  • Charlesson LLC. - Pipeline by Route of Administration, 2015
  • Charlesson LLC. - Pipeline by Molecule Type, 2015
  • Charlesson LLC. - Pipeline Products by Mechanism of Action, 2015
  • Charlesson LLC. - Dormant Developmental Projects,2015

List of Figures

  • Charlesson LLC. - Pipeline by Top 10 Indication, 2015
  • Charlesson LLC. - Pipeline by Stage of Development, 2015
  • Charlesson LLC. - Monotherapy Products in Pipeline, 2015
  • Charlesson LLC. - Pipeline by Top 10 Target, 2015
  • Charlesson LLC. - Pipeline by Top 10 Molecule Type, 2015
  • Charlesson LLC. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top